Research published in *Immunity & Ageing* shows STING hyperactivation suppresses the JAK-STAT pathway in CD4+ T cells from aging people living with HIV-1, even when viral load is controlled on antiretroviral therapy. Investigators used time-course transcriptomics from CD4+ T cells stimulated ex vivo in 58 participants, then validated findings in an expanded cohort of 120 using flow cytometry, qPCR, and cytokine profiling. The study reports coordinated gene changes that reflect combined effects of chronological aging and HIV-1 infection, with STING (cGAS-STING signaling) elevated in older participants with HIV. The higher STING signal correlated with CD4+ T cell depletion, and mechanistic experiments using Jurkat models and targeted pharmacologic inhibition supported a causal link to signaling dysregulation. For therapeutic development, the results reinforce that immune dysfunction in older PLWH is not solely driven by residual viral replication, but also by innate-sensing circuitry that can reshape downstream transcriptional programs. Targeting STING-related nodes may therefore be a potential immunomodulation direction, though clinical translation will require careful safety evaluation.